Retinal ganglion cell (RGC) survival is critical for vision, but these neurons are exquisitely sensitive to insults. In acute diseases such as ischaemic optic neuropathy or optic neuritis, or in chronic diseases such as glaucoma, injury to RGC axons in the optic nerve may lead to rapid RGC death. Retinal ischaemia and retinal artery or vein occlusions directly injure RGC cell bodies in the ganglion cell layer. Enhancing RGC viability (neuroprotection) or RGC function (neuroenhancement) remains a major goal of basic and translational research. In this article we review the many mechanisms that lead from such insults to RGC death in clinically relevant pathological processes, and discuss avenues being pursued to enhance RGC survival in human disease.
excitotoxicity deprives the cell of the minimum required energy (intracellular adenosine triphosphate [ATP] ) to support the basic cellular metabolism, or disrupts cellular metabolism in such a way that processes necessary to maintain normal membrane permeability and integrity are paralysed. Cells and mitochondria swell, with early fenestration of the membrane, scattered condensation of the nuclear chromatin 5 and loss of the ability to isolate intracellular components from the extracellular environment. In the process of dying, these cells release ions, proteins and neurotransmitters that have the potential to kill off neighbouring cells. This extension of necrosis to (and induction of apoptosis in) cells that were not originally injured can lead to considerable secondary damage. The process finishes with extensive phagocytic clean-up (which also releases additional pro-inflammatory mediators and free radicals). Retinal ischaemia, as in retinal artery and vein occlusions, leads to RGC death by necrosis.
On the other hand, apoptosis comprises the molecular processes of programmed cell death, with sequential degradation of intracellular organelles and final clean-up by phagocytic cells. This process is thought to minimise the release of toxic intracellular components into the extracellular environment and is the mechanism observed during development and neurodegeneration to target cells for destruction without affecting neighbouring cells that are integrated to survive. 2 Most optic nerve damage -as in traumatic or ischaemic optic neuropathies or glaucoma -is thought to lead to RGC death by apoptosis. Anti-apoptotic Signals In these cases, RGC physiological mechanisms that bind and inactivate ROS, including production of free radical scavengers, catalase and glutathione peroxidase, 42 are overwhelmed. ROS interfere with normal cellular function not only by oxidising proteins, nucleic acids and lipids, but also by directly activating the apoptotic process of cell death. 43 Free radical scavengers such as edaravone are able to increase RGC survival in vivo by inhibiting ROS-induced activation of the proapoptotic JNK and P38 signalling pathways. 43 Genetic approaches to overexpress some of these intrinsic antioxidant proteins in animal models have shown promising effectiveness in decreasing RGC death, 44 and a number of antioxidants are entering clinical trials as neuroprotectants.
Pro-apoptotic Signals
Any initial RGC death, particularly from ischaemia-induced necrotic release of cellular contents, can lead to secondary cell death, which may be caused by excitotoxicity. Excitotoxicity is thought to occur when excessive activation of glutamate or other channels (e.g. from glutamate spilling into the extracellular space from dying cells), and specifically of N-methyl-D-aspartate (NMDA)-sensitive glutamate channels, leads to a deleterious increase in intracellular calcium and subsequent activation of pro-apoptotic signalling pathways. 45 However, excitotoxicity is more complex than initially thought, and depends on the duration, location and intensity of glutamate channel activation, 46 as some level of electrical activity may be protective (see below). In hippocampal neurons, neuroprotection has been shown to be related to preferential activation of synaptic NMDA receptors, and excitotoxicity with activation of non-synaptic ones, 47 These external insults can also lead to other cellular dysregulation.
For example, accumulation of abnormal proteins, such as hyperphosphorylated Tau AT8, have been described in the retina of glaucoma patients. 54 Abnormal folding of proteins inside the endoplasmic reticulum (ER) leads to 'ER stress' and severe cellular dysfunction, again associated with RGC apoptosis. ER stress is present preferentially in the ganglion cell layer 24 hours after intravitreal NMDA injection or elevation of the IOP. 55 The significance of ER stress is still under investigation to determine whether the phenomenon is a cause or just part of the process of cell death.
Neurotrophic Deprivation, Decreased Electrical Activity and Retinal Ganglion Cell Death
RGCs depend on trophic signals from their neighbours in the retina, in the optic nerve and in their targets in the brain for survival. 56 Targetderived growth factors 3 such as brain-derived growth factor (BDNF) are taken up by RGC axon terminals and travel retrogradely through the axon, down the optic nerve and back to the cell body in the retina. 57 RGC dependence on target-derived BDNF seems to be more important during formation of early axon connections with their targets in the brain, 58, 59 but may switch to dependence on other sources, such as other retinal cells, including amacrine cells and
Muller glia during development and into adulthood. 60, 61 Similarly, other trophic factors, such as fibroblast growth factor-2 (FGF2), glial-derived neurotrophic factor (GDNF), insulin-like growth factors (IGFs) and ciliary neurotrophic factor (CNTF), strongly support RGC survival. For example, lentiviral-mediated transfer of CNTF into schwann cells placed in a peripheral nerve graft to repair rat optic nerve after injury also significantly increased RGC survival. 62 Indeed, 72, 73 These data raise the hypothesis that one of the reasons RGCs die after injury is that they are less electrically active. 74 How does electrical activity increase cAMP in RGCs? Increases in cAMP and subsequent enhancement of neurotrophic responsiveness likely depend on calcium-sensitive adenylyl cyclases (ACs). 75 Most attention has focused on the transmembrane ACs, which are activated pharmacologically by forskolin, a drug that can potentiate RGC trophic responsiveness in a manner similar to depolarisation.
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growth-factor-free media. 89 Currently, clinical trials are ongoing to determine a possible therapeutic effect of intranasal and intravenous formulations of some of these peptides in Alzheimer's disease and other neurodegenerative diseases. 
